Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
C$0.07
-6.7%
C$0.07
C$0.07
C$0.42
C$15.76MN/A708,229 shs152,117 shs
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$5.30
+0.6%
$5.17
$4.32
$14.45
$728.51M1.221.35 million shs914,201 shs
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
C$0.29
+5.5%
C$0.21
C$0.04
C$0.36
C$43.94M0.32197,328 shs113,826 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%0.00%
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
0.00%0.00%0.00%0.00%0.00%
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
+0.57%+3.72%-2.75%-7.34%-37.13%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
+5.45%-12.12%+52.63%+70.59%+480.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
3.1902 of 5 stars
3.42.00.00.02.13.31.3
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HEXO Corp. stock logo
HEXO
HEXO
0.00
N/AN/AN/A
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
0.00
N/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
2.86
Moderate Buy$32.86519.95% Upside
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest NRTH, VM, HEXO, and VIR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/22/2025
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$14.00 ➝ $14.00
5/12/2025
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$19.00 ➝ $14.00
4/17/2025
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$28.00 ➝ $21.00
(Data available from 7/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
C$18.90M0.83C$0.01 per share8.75C$0.15 per share0.47
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
$74.21M9.87N/AN/A$8.35 per share0.63
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AC$0.01 per share35.00C$0.01 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
N/A-C$0.23N/AN/AN/AN/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-$521.96M-$4.22N/AN/AN/A-2,769.04%-47.46%-39.33%7/30/2025 (Estimated)
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
-C$1.66M-C$0.01N/AN/AN/A-117.77%-30.77%N/A

Latest NRTH, VM, HEXO, and VIR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
-$0.83-$0.88-$0.05-$0.88$8.59 million$3.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
N/AN/AN/AN/AN/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
N/AN/AN/AN/AN/A
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
18.28
1.29
0.34
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
N/A
6.79
6.79
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
4.23
0.10
0.84

Institutional Ownership

CompanyInstitutional Ownership
HEXO Corp. stock logo
HEXO
HEXO
7.78%
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
N/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
65.32%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A

Insider Ownership

CompanyInsider Ownership
HEXO Corp. stock logo
HEXO
HEXO
4.69%
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
N/A
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
16.00%
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
10.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
48North Cannabis Corp. stock logo
NRTH
48North Cannabis
47225.17 millionN/ANot Optionable
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
580138.24 million116.12 millionOptionable
Voyageur Pharmaceuticals Ltd. stock logo
VM
Voyageur Pharmaceuticals
N/A151.52 millionN/ANot Optionable

Recent News About These Companies

Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Here's Why
Voyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Should You Sell?
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% - Time to Sell?
Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 11.5% - Here's Why
Voyageur Pharmaceuticals (CVE:VM) Shares Down 11.5% - Here's Why

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
HEXO stock logo

HEXO NYSE:HEXO

HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.

48North Cannabis stock logo

48North Cannabis CVE:NRTH

C$0.07 -0.01 (-6.67%)
As of 09/2/2021

48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada. The company offers bath salts, intimacy oils, flowers, pre-rolls, body cream and oil, vapes, pressed hash, and accessories under 48North, Apothecanna, First Harvest, Avitas, F8, Trail Mix, and Latitude brands. It also provides LAT, a publication and creative platform that empowers women to connect, engage, and learn through their experiences with cannabis. 48North Cannabis Corp. is headquartered in Toronto, Canada.

Vir Biotechnology stock logo

Vir Biotechnology NASDAQ:VIR

$5.30 +0.03 (+0.57%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$5.32 +0.02 (+0.45%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Vir Biotechnology, Inc., an immunology company, develops therapeutic products to treat and prevent serious infectious diseases. Its clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). The company's preclinical candidates include those targeting influenza A and B, coronavirus disease 2019, respiratory syncytial virus (RSV) and human metapneumovirus (MPV), and human papillomavirus (HPV). The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune, LLC; collaboration with WuXi Biologics (Hong Kong) Limited and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A, as well as license agreement with Sanofi for three clinical-stage masked T-cell engagers (TCEs) and exclusive use of the protease-cleavable masking platform for oncology and infectious diseases. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Voyageur Pharmaceuticals stock logo

Voyageur Pharmaceuticals CVE:VM

C$0.29 +0.02 (+5.45%)
As of 07/8/2025 01:16 PM Eastern

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.